Accendra Health, Inc. · NYSE:ACH
Accendra Health — Owens & Minor — Q3 2018 Earnings Presentation
10 slides from Accendra Health's earnings presentation, Oct 31, 2018
Slide 1: 3rd Quarter 2018 Earnings
3rd Quarter 2018 Earnings October 31, 2018 1
Slide 2: Safe Harbor
Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non- exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation contains certain ''forward-looking'' statements made pursuant to th
Slide 3: Presenters: Cody Phipps and Robert Snead
Cody Phipps Chairman, President & CEO Robert Snead Interim CFO, GVP Global Solutions 6
Slide 4: Highlights
Highlights . Revenue growth of 5.6% for 3Q18 with contributions from Byram and Halyard . Global Solutions . Efficiency improvement and operating performance are top priorities . Byram continues to exceed our expectations . Global Products . Halyard revenue growth on track . Higher production costs a
Slide 5: 3Q18 Summary – GAAP Reported Results
3Q18 Summary – GAAP Reported Results . Revenue growth driven by (S in millions, except per share amounts) % change Byram and Halyard revenue 3Q18 3Q17 Fav/(Unfav) contributions Net revenue $2,464.9 $2,334.0 5.6% . Gross margin negatively affected by $6.6 million Gross margin 352.6 301.9 16.8% increa
Slide 6: 3Q18 Summary – Adjusted Results
3Q18 Summary – Adjusted Results . Revenue growth for the quarter of 5.6% includes (S in millions, except per share amounts) % change contributions of $61 million 3Q18 3Q17 Fav/(Unfav) from Byram and $240 million from Halyard (before Net revenue $2,464.9 $2,334.0 5.6% elimination of $52 million Gross
Slide 7: Global Solutions Results
Global Solutions Results (S in millions) Q318 Q317 % change Net revenue $2,243.8 $2,290.8 -2% Operating Income 24.2 37.6 -36% . Byram, acquired in August 2017, contributed $61 million to quarterly revenue growth . Results negatively affected by: . Lower than expected growth from new and existing cus
Slide 8: Global Products Results
Global Products Results (S in millions) Q318 Q317 % change Net revenue $349.9 $124.5 nm Operating Income 27.6 10.5 nm . Results reflect full quarter of Halyard contribution, $240 million in revenues . Operating income increase driven primarily by Halyard contributions . Higher production costs expec
Slide 9: Balance Sheet/Capital Deployment
Balance Sheet/Capital Deployment . Dividend of $0.075 per share declared by the board for the 4th quarter of 2018, representing a $0.185 per share reduction . Cash balance at September 30, 2018 was $125 million . Year-to-date operating cash flow of $123 million . Long-term debt of $1.64 billion at S
Slide 10: GAAP/Non-GAAP Reconciliation
GAAP/Non-GAAP Reconciliation (dollars in thousands, except per share data) Three Months Ended September 30, 2018 2017 Operating income (loss), as reported (GAAP) $ 21,357 $ 29,671 Acquisition-related intangible amortization 10,366 5,071 Acquisition-related and exit and realignment charges 7,727 9,29